The Predicted 3D Structures of the Human M1 Muscarinic Acetylcholine Receptor with Agonist or Antagonist Bound
暂无分享,去创建一个
Nagarajan Vaidehi | William A Goddard | W. Goddard | N. Vaidehi | Spencer Hall | Spencer E Hall | Joyce Yao-chun Peng | J. Peng | Joyce Peng
[1] Olgun Guvench,et al. Tryptophan side chain electrostatic interactions determine edge-to-face vs parallel-displaced tryptophan side chain geometries in the designed beta-hairpin "trpzip2". , 2005, Journal of the American Chemical Society.
[2] Nagarajan Vaidehi,et al. Test of the Binding Threshold Hypothesis for olfactory receptors: Explanation of the differential binding of ketones to the mouse and human orthologs of olfactory receptor 912‐93 , 2005, Protein science : a publication of the Protein Society.
[3] J. Kelly,et al. Toward assessing the position-dependent contributions of backbone hydrogen bonding to beta-sheet folding thermodynamics employing amide-to-ester perturbations. , 2004, Journal of the American Chemical Society.
[4] Brendan J. Howlin,et al. Antagonist binding in the rat muscarinic receptor: A study by docking and X-ray crystallography , 2004, Comput. Biol. Chem..
[5] Nagarajan Vaidehi,et al. Predicted 3-D structures for mouse I7 and rat I7 olfactory receptors and comparison of predicted odor recognition profiles with experiment. , 2004, Chemical senses.
[6] Nagarajan Vaidehi,et al. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin. , 2004, Biophysical journal.
[7] T. Sixma,et al. Nicotine and Carbamylcholine Binding to Nicotinic Acetylcholine Receptors as Studied in AChBP Crystal Structures , 2004, Neuron.
[8] Peter L. Freddolino,et al. The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Peter L. Freddolino,et al. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] Christian C. Felder,et al. Use of M1–M5 Muscarinic Receptor Knockout Mice as Novel Tools to Delineate the Physiological Roles of the Muscarinic Cholinergic System , 2003, Neurochemical Research.
[11] William A. Goddard,et al. Fidelity of Phenylalanyl-tRNA Synthetase in Binding the Natural Amino Acids , 2003 .
[12] Rodrigo Lopez,et al. Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..
[13] Wely B. Floriano,et al. Interaction of e. coli outer‐membrane protein A with sugars on the receptors of the brain microvascular endothelial cells , 2002, Proteins.
[14] Didier Rognan,et al. Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.
[15] J. Saldanha,et al. Structure and activation of muscarinic acetylcholine receptors. , 2001, Biochemical Society transactions.
[16] E C Hulme,et al. Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor. , 2003, Receptors & channels.
[17] Nagarajan Vaidehi,et al. Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase. , 2002, Journal of the American Chemical Society.
[18] Shigeyuki Yokoyama,et al. Conformation of ligands bound to the muscarinic acetylcholine receptor. , 2002, Molecular pharmacology.
[19] Peter L. Freddolino,et al. Prediction of structure and function of G protein-coupled receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] W. Goddard,et al. Structure-based design of mutant Methanococcus jannaschii tyrosyl-tRNA synthetase for incorporation of O-methyl-l-tyrosine , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] W. Messer. Cholinergic agonists and the treatment of Alzheimer's disease. , 2002, Current topics in medicinal chemistry.
[22] W. Goddard,et al. Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[24] J W Saldanha,et al. Transmembrane Domains 4 and 7 of the M1Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch* , 2001, The Journal of Biological Chemistry.
[25] R. Eglen,et al. Therapeutic opportunities from muscarinic receptor research. , 2001, Trends in pharmacological sciences.
[26] C. Strader,et al. Muscarinic agonists and antagonists in the treatment of Alzheimer's disease. , 2001, Farmaco.
[27] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[28] G M Shepherd,et al. Molecular mechanisms underlying differential odor responses of a mouse olfactory receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. Page,et al. Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M(1) muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine. , 2000, Molecular pharmacology.
[30] E. Hulme,et al. A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor* , 2000, The Journal of Biological Chemistry.
[31] D. Case,et al. Generalized born models of macromolecular solvation effects. , 2000, Annual review of physical chemistry.
[32] E. Hulme,et al. Alanine-scanning mutagenesis of transmembrane domain 6 of the M(1) muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function. , 1999, Molecular pharmacology.
[33] E C Hulme,et al. The Functional Topography of Transmembrane Domain 3 of the M1 Muscarinic Acetylcholine Receptor, Revealed by Scanning Mutagenesis* , 1999, The Journal of Biological Chemistry.
[34] Xi-Ping Huang,et al. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors , 1999, British journal of pharmacology.
[35] G. Schertler,et al. Structure of rhodopsin , 1998, Eye.
[36] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[37] D. Sheehan,et al. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling. , 1997, Molecular pharmacology.
[38] Todd J. A. Ewing,et al. Critical evaluation of search algorithms for automated molecular docking and database screening , 1997, J. Comput. Chem..
[39] Susanne Trumpp-Kallmeyer,et al. Modelling of the binding site of the human m1 muscarinic receptor: Experimental validation and refinement , 1997, J. Comput. Aided Mol. Des..
[40] Roland L. Dunbrack,et al. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.
[41] E. Hulme,et al. The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. , 1997, Molecular pharmacology.
[42] D A Dougherty,et al. Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] E C Hulme,et al. Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. , 1994, The Journal of biological chemistry.
[44] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[45] J. Venter,et al. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.
[46] R. Lathe. Phd by thesis , 1988, Nature.
[47] G A Petsko,et al. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.
[48] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .